Media

Support Of Industry Underscores Pro-Business Commitment
Commercialization of cleaner, safer consumer products through innovative industrial biotechnology processes will be the focus of breakout sessions at the...

Press Releases

Jul 13 2000
WASHINGTON, D.C. (July 13, 2000) Executives from two Biotechnology Industry Organization (BIO) member companies testified today at a U.S. House Judiciary...
Jul 12 2000
WASHINGTON, D.C. (July 12, 2000) - Executives from two Biotechnology Industry Organization (BIO) member companies will testify Thursday, July 13, at a U.S....
Jul 11 2000
WASHINGTON, D.C. (July 11, 2000) - The Biotechnology Industry Organization (BIO) endorses recommendations contained in a report, released today, from the U.S....
Jun 30 2000
(Dr. Val Giddings, vice president for food and agriculture of the Biotechnology Industry Organization (BIO) issued the following statement in response to today...
Jun 29 2000
WASHINGTON, D.C. (June 29, 2000) - Nancy Myers, health-care policy counsel for the Biotechnology Industry Organization (BIO), said House approval of a...
Jun 22 2000
WASHINGTON, D.C. (June 22, 2000) --The Biotechnology Industry Organization (BIO) today applauded Congress and President Clinton for their support of research...
Jun 22 2000
WASHINGTON, D.C. (June 22, 2000) --TheBiotechnology Industry Organization (BIO) has named Missouri Gov. Mel Carnahan Governor of the Year for his support of...
Jun 20 2000
WASHINGTON, D.C. (June 20, 2000) - Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement on an...
Jun 13 2000
WASHINGTON, D.C. (June 13, 2000) - Paul Abrams, CEO of NeoRx Corp., testified today on behalf of the Biotechnology Industry Organization (BIO) at a U.S. Senate...


Biotechnology News

September 20, 2014

MONT-TREMBLANT, Quebec--(BUSINESS WIRE)--FibroGen, Inc. (FibroGen) announced today the presentation of the full data set from a clinical study of patients with idiopathic...

September 19, 2014

LOS ANGELES--(BUSINESS WIRE)--Contact Glancy Binkow & Goldberg LLP if you purchased PDL BioPharma, Inc. securities between November 6, 2013 and September 16, 2014.

September 19, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a...

September 19, 2014

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research will present at BioCentury’s 21st Annual NewsMakers in the Biotech Industry conference on September 26, 2014 at 10:30...

September 19, 2014

PARIS & COPENHAGEN, Denmark--(BUSINESS WIRE)--Regulatory News: Onxeo SA (Paris:ONXEO) (NASDAQ OMX:ONXEO) (Euronext Paris, NASDAQ OMX Copenhagen - ONXEO), an innovative...